Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Rodrigo López-Muñoz

6PUBLICATIONS

13CO-AUTHORS

Molecular targetsLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Molecular medicinePredictive and prognostic markers

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Feb 20, 2026

The polyamine inhibitor SAM486A increases the efficacy of adagrasib in non-small cell lung cancer cells harboring KRAS<sup>G12C</sup> mutation.

Antonia Martin-Martin, Carina Chipón, Constanza Guzman-Kunstmann

|Nov 09, 2024

Impact of Nordihydroguaiaretic Acid on Proliferation, Energy Metabolism, and Chemosensitization in Non-Small-Cell Lung Cancer (NSCLC) Cell Lines.

Carina Chipón, Paula Riffo, Loreto Ojeda

|Oct 25, 2024

Dual-Action Gemcitabine Delivery: Chitosan-Magnetite-Zeolite Capsules for Targeted Cancer Therapy and Antibacterial Defense.

Yuly Andrea Guarín-González, Gerardo Cabello-Guzmán, José Reyes-Gasga

|Sep 28, 2023

Indomethacin Induces Spermidine/Spermine-N<sup>1</sup>-Acetyltransferase-1 via the Nucleolin-CDK1 Axis and Synergizes with the Polyamine Oxidase Inhibitor Methoctramine in Lung Cancer Cells.

Neudo Buelvas, Isidora Ugarte-Vio, Laura Asencio-Leal

|Jun 10, 2023

Mind the Curve: Dose-Response Fitting Biases the Synergy Scores across Software Used for Chemotherapy Combination Studies.

Olga Fuentealba-Manosalva, Matías Mansilla, Neudo Buelvas

|May 22, 2019

Reconsidering the Role of Cyclooxygenase Inhibition in the Chemotherapeutic Value of NO-Releasing Aspirins for Lung Cancer.

Antonia Martin-Martin, Andrés Rivera-Dictter, Matías Muñoz-Uribe

Pageof 1

Frequent Collaborators

1 joint publications

Cristian G Torres

1 joint publications

Matías Muñoz-Uribe

1 joint publications

Julio C Tapia

1 joint publications

Yuly Andrea Guarín-González

1 joint publications

Gerardo Cabello-Guzmán

1 joint publications

José Reyes-Gasga

1 joint publications

Yanko Moreno-Navarro

1 joint publications

Luis Vergara-González

1 joint publications

Galo Cárdenas-Triviño

1 joint publications

Luis F Barraza

Frequent Collaborators

1 joint publications

Cristian G Torres

1 joint publications

Matías Muñoz-Uribe

1 joint publications

Julio C Tapia

1 joint publications

Yuly Andrea Guarín-González

Top Related Videos

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on : Jun 26, 2019

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on : Jun 09, 2023

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on : May 22, 2020

See more related videos

Top Related Videos

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on : Jun 26, 2019

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on : Jun 09, 2023

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on : May 22, 2020

See more related videos